Cancer Research Donn Young  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, R. G.
Right arrow Articles by Iavarone, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, R. G.
Right arrow Articles by Iavarone, A.
[Cancer Research 64, 7220-7225, October 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Id2 Drives Differentiation and Suppresses Tumor Formation in the Intestinal Epithelium

Robert G. Russell1, Anna Lasorella2,3,4, Luis E. Dettin1 and Antonio Iavarone3,4,5

1 Lombardi Cancer Center, Department of Oncology, Georgetown University, Washington, D. C.; 2 Department of Pediatrics, 3 Institute for Cancer Genetics, 4 Department of Pathology, and 5 Department of Neurology, College of Physicians and Surgeons of Columbia University, New York, New York

Oncogenic signals elevate expression of Id2 in multiple tumor types. When deregulated, Id2 inactivates the tumor suppressor proteins retinoblastoma, p107, and p130. Here, we report a novel and unexpected tumor inhibitory function of Id2 in the intestinal epithelium. First, genetic ablation of Id2 in the mouse prevents differentiation and cell cycle arrest of enterocytes at the time of formation of the crypt-villus unit. Later, these developmental abnormalities evolve toward neoplastic transformation with complete penetrance. Id2-null tumors contain severe dysplastic and metaplastic lesions and express aberrant amounts of ß-catenin. Thus, our data are the first to establish a direct requirement of basic helix-loop-helix inhibitors in driving differentiation and define an unexpected role for the retinoblastoma-binding protein Id2 in preventing tumor formation.




This article has been cited by other articles:


Home page
Cancer Res.Home page
W. Yan, G. Liu, A. Scoumanne, and X. Chen
Suppression of Inhibitor of Differentiation 2, a Target of Mutant p53, Is Required for Gain-of-Function Mutations
Cancer Res., August 15, 2008; 68(16): 6789 - 6796.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. K. Swamynathan, J. Davis, and J. Piatigorsky
Identification of Candidate Klf4 Target Genes Reveals the Molecular Basis of the Diverse Regulatory Roles of Klf4 in the Mouse Cornea
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3360 - 3370.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Jankiewicz, B. Groner, and S. Desrivieres
Mammalian Target of Rapamycin Regulates the Growth of Mammary Epithelial Cells through the Inhibitor of Deoxyribonucleic Acid Binding Id1 and Their Functional Differentiation through Id2
Mol. Endocrinol., October 1, 2006; 20(10): 2369 - 2381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Renne, J. I. Martin-Subero, M. Eickernjager, M.-L. Hansmann, R. Kuppers, R. Siebert, and A. Brauninger
Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma
Am. J. Pathol., August 1, 2006; 169(2): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D. Onken, J. P. Ehlers, L. A. Worley, J. Makita, Y. Yokota, and J. W. Harbour
Functional Gene Expression Analysis Uncovers Phenotypic Switch in Aggressive Uveal Melanomas.
Cancer Res., May 1, 2006; 66(9): 4602 - 4609.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Bloethner, B. Chen, K. Hemminki, J. Muller-Berghaus, S. Ugurel, D. Schadendorf, and R. Kumar
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
Carcinogenesis, July 1, 2005; 26(7): 1224 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Lasorella, G. Rothschild, Y. Yokota, R. G. Russell, and A. Iavarone
Id2 Mediates Tumor Initiation, Proliferation, and Angiogenesis in Rb Mutant Mice
Mol. Cell. Biol., May 1, 2005; 25(9): 3563 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Batsche, P. Moschopoulos, J. Desroches, S. Bilodeau, and J. Drouin
Retinoblastoma and the Related Pocket Protein p107 Act as Coactivators of NeuroD1 to Enhance Gene Transcription
J. Biol. Chem., April 22, 2005; 280(16): 16088 - 16095.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Gregorieff and H. Clevers
Wnt signaling in the intestinal epithelium: from endoderm to cancer
Genes & Dev., April 15, 2005; 19(8): 877 - 890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.